Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire

Tropical Medicine and International Health

Volumn 16, Issue 3, 2011, Pages 290-297

  Toure, Offianan A ^a   Kouame, Menan G ^a   Didier, Yapi J ^a   Berenger, Ako A A ^a   Djerea, Khali ^b   Genevieve, Gomez O ^b   Penali, Louis K ^a  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b Anonkoua koute Health Centre   (Côte d’Ivoire)

Author keywords

Artemether lumefanthrine; Children; falciparum malaria Artesunate mefloquine; Uncomplicated malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEQUIN PAEDIATRIC; ARTESUNATE PLUS MEFLOQUINE; UNCLASSIFIED DRUG;

CHILD HEALTH; DISEASE TREATMENT; DRUG DEVELOPMENT; MALARIA; POLYMERASE CHAIN REACTION;

ABDOMINAL PAIN; ANOREXIA; ARTICLE; ASTHENIA; CHILD; COMPARATIVE EFFECTIVENESS; COTE D'IVOIRE; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OPEN STUDY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SIDE EFFECT; TREATMENT OUTCOME; VOMITING;

ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DRUG COMBINATIONS; EPIDEMIOLOGIC METHODS; ETHANOLAMINES; FEMALE; FEVER; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

COTE D'IVOIRE;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 79951763517     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02701.x     Document Type: Article

References (17)

1. Agomo P, Meremikwu MM, Watila IM et al. (2008) Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria. Malaria Journal 7, 172.
2. Ashley EA, Lwin KM, McGready R et al. (2006) An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Tropical Medicine and International Health 11, 1653-1660.
3. Bouyou-Akotet MK, Ramharter M, Ngoungou EB et al. (2010) Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon. Wiener Klinische Wochenschrift 122 Numbers 5-6, 173-178.
4. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ & Dorsey G (2003) Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug-efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. American Journal of Tropical Medicine and Hygiene 68, 133-139.
5. Djimdé A & Lefèvre G (2009) Understanding the pharmacokinetics of Coartem® Malaria Journal 8, (Suppl. 1), S4.
6. Faye B, Ndiaye JL, Tine R et al. (2010) A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children. American Journal of Tropical Medicine and Hygiene 82, 140-144.
7. Nosten F & White NJ (2007) Artemisinin-based combination treatment of falciparum malaria. American Journal of Tropical Medicine and Hygiene 77 (Suppl 6), 181-192.
8. Premji ZG, Abdulla S, Ogutu B et al. (2008) The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence. Malaria Journal 7, 244.
9. Ramharter M, Kurth FM, Bélard S et al. (2007) Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. Journal of Antimicrobial Chemotherapy 60, 1091-1096.
10. Rogers WO, Sem R, Tero T et al. (2009) Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malaria Journal 8, 10.
11. Sagara I, Diallo A, Kone M et al. (2008) A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. American Journal of Tropical Medicine and Hygiene 79, 655-661.
12. Sinclair D, Zani B, Donegan S et al. (2009) Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database of Systematic Reviews 3, CD007483.
13. Tietche F, Chelo D, Ntoto NK et al. (2010) Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene 82, 1034-1040.
14. Valecha N, Phyo AP, Mayxay M et al. (2010) An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS ONE 5, e11880. doi:
15. World Health Organization (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria, Vol 50. WHO/HTM/RBM, Geneva, 1-68.
16. World Health Organization (2007) Methods and techniques for clinicals trials on antimalarial drug efficacy: genotyping to identify parasites population. Informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organisation 29-31 May 2007, Amsterdam, the Netherlands.
17. World Health Organization (2010) Guidelines for the Treatment of Malaria, 2nd edn. World Health Organization, Geneva.